|
|
Saquinavir (Fortovase, Invirase) Research
- The GEMINI Study: Are Saquinavir + Ritonavir and Lopinavir/Ritonavir Twins? (November 16, 2006)
In 8th International Congress on Drug Therapy in HIV Infection
- Research From the 42nd ICAAC: Two PIs vs. Two PIs vs. Efavirenz (December 2002)
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Protease Inhibitors Compared: Studies Examine Dosing, Cholesterol Levels Among Patients Using Fortovase, Invirase (June/July 2002)
In Positive Living, from AIDS Project Los Angeles
- Saquinavir/Mini-Dose Ritonavir Highly Potent in Treatment-Naive Patients (March/April 2002)
In Body Positive, from Body Positive
- Garlic and Saquinavir Interactions (February 8, 2002)
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project
- Garlic Reduces Saquinavir Blood Levels 50%; May Affect Other Drugs (December 21, 2001)
To read PDF, click here
In AIDS Treatment News, from AIDS Treatment News
- Once-Daily Atazanavir Plus Saquinavir Favorably Affects Total Cholesterol (TC) and Fasting Triglyceride (TG) Profiles in Patients Failing Prior PI Therapy (Trial AI424-009, Week 24) (December 18, 2001)
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO
- Garlic Supplements Can Impede HIV Medication (December 5, 2001)
From U.S. National Institute of Allergy and Infectious Diseases
- A Phase IV Randomized Open-Label Multicenter Trial to Evaluate Safety and Efficacy of Indinavir/Ritonavir (800/100 mg BID) vs. Saquinavir/Ritonavir (1,000/100 mg BID) in Adult HIV-1 Infection: The Max Cmin 1 Trial (October 29, 2001)
In 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, from The Body PRO
- Minor Interaction Between Efavirenz and Saquinavir When Combined With Small Doses of Ritonavir in a QD Regimen (October 28, 2001)
In 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, from The Body PRO
- Tolerability and Antiviral Activity of Fortovase Plus Ritonavir (May 2001)
In HEPP News, from Brown Medical School
- From Grapefruit Juice to Ritonavir (March 15, 2001)
From Canadian AIDS Treatment Information Exchange
- Adding Ritonavir to Boost Saquinavir (Spring 2001)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Garlic Supplements Decrease Saquinavir Plasma Concentrations (February 7, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Protease Inhibitor Boosting Enhances Saquinavir Therapy (January 2001)
Highlights from ICAAC 2000.
In Body Positive
- Randomized Salvage Therapy With Saquinavir-Ritonavir (SQV-RTV) Versus Saquinavir-Nelfinavir (SQV-NFV) for Highly Experienced HIV-Infected Patients (September 17, 2000)
In The 40th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- Combining Amprenavir or Saquinavir With Efavirenz (Spring 2000)
Selected highlights from the 7th CROI.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Saquinavir and Ritonavir Dosing Should Not Be Staggered (Spring 2000)
Selected highlights from the 7th CROI.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Saquinavir Plus Ritonavir and Drugs Used to Reduce High Cholesterol (Spring 2000)
Selected highlights from the 7th CROI.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Phenotypic Resistance to Protease Inhibitors Predicts Outcome of a Five Drug Combination Including Ritonavir, Saquinavir and Efavirenz in Patients Who Failed on HAART (September 29, 1999)
In The 39th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- The Efficacy of Ritonavir (RTV)/Saquinavir (SQV) Antiretroviral Therapy (ART) in Patients Who Failed Nelfinavir (NFV): A Multi-Center Clinical Cohort Study (September 29, 1999)
In The 39th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- Pharmakokinetic (PK) Interactions Between the HIV Protease Inhibitors Ritonavir (RTV) and Saquinavir (SQV) and VIAGRA (Sildenafil Citrate) (September 27, 1999)
In The 39th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- A Study in HIV Positive Women of Quadruple Therapy: Nelfinavir, Saquinavir, Stavudine, and Lamivudine (February 4, 1998)
From Seattle Treatment Education Project
- Safety of Saquinavir Soft Gelatin Capsule (SQV-SGC) With Other Antiviral Agents (September 28 - October 1, 1997)
In The 37th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- Saquinavir Soft Gel Capsules Versus Indinavir as Part of AZT and 3TC Containing Triple Therapy (September 28-October 1, 1997)
In The 37th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- Effects of Switching From Saquinavir Hard Capsule (SQV-HC) to Saquinavir Soft Gel Capsules (SQV-SGC) or Indinavir (IDV) (September 1997)
In The 35th Annual Meeting of the Infectious Diseases Society of America, from The Body PRO
- Roche Racks Up Millions in Early Saquinavir Sales While Unwitting Patients Prime Themselves for Protease X-Resistance (August 1997)
In TAGline, from Treatment Action Group
- Saquinavir: Major Study Shows Survival Benefit in Treatment-Naive Patients (July 4, 1997)
From AIDS Treatment News
- Ritonavir-Saquinavir Combination Therapy in Patients with Advanced HIV Infection (January 1997)
In The 4th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
|
|
